While HERV-W Env antigen is detectable in the serum of 73% of MS patients (and 0% of healthy controls), it does not appear that HERV-W antigen levels are directly correlated to the severity of the symptoms [72]. This evidence concerns the gene ERVW-1 and myeloid sarcoma.